Babatunde Olaiya1, Parit Mekaroonkamol2,3, Bai-Wen Li2,4, Julia Massaad2, Cicily T Vachaparambil2, Jennifer Xu2, Vladamir Lamm2, Hui Luo5, Shan-Shan Shen6, Hui-Min Chen7, Steve Keilin2, Field F Willingham2, Qiang Cai2. 1. Department of Internal Medicine, Marshfield Clinic, Marshfield, WI, USA. 2. Division of Digestive Diseases, Emory University School of Medicine, Atlanta, GA, USA. 3. Division of Gastroenterology, King Chulalongkorn Memorial Hospital, Chulalongkorn University and Thai Red Cross, Bangkok, Thailand. 4. Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai, P. R. China. 5. Department of Gastroenterology, Xijing Hospital, Xi'an, Shaanxi, P. R. China. 6. Department of Gastroenterology, Nanjing Drum Tower Hospital, Nanjing, Jiangshu, P. R. China. 7. Department of Gastroenterology, Renji Hospital, Shanghai Jiaotong University, Shanghai, P. R. China.
Abstract
BACKGROUND: Fluoroscopy is often used during the endoscopic drainage of pancreatic-fluid collections (PFCs). An electrocautery-enhanced coaxial lumen-apposing, self-expanding metal stent (ELAMS) facilitates a single-step procedure and may avoid the need for fluoroscopy. This study compares the treatment outcomes using ELAMS with and without fluoroscopy. METHODS: Patients with PFCs who had cystogastrostomy from January 2014 to February 2017 were enrolled. Two groups were studied based on fluoroscopy use. Technical success was defined as uneventful insertion of ELAMS at time of procedure. Clinical success was defined as (i) clinical resolution of symptoms after the procedure and (ii) >75% reduction in cyst size on computed tomography 8 weeks after stent placement. Adverse events including bleeding, stent migration, and infection were recorded. RESULTS: A total of 21 patients (13 males) had PFCs drainage with ELAMS in the study period. The mean age was 51.6 ± 14.2 years. Thirteen patients had walled-off necrosis while eight had a pancreatic pseudocyst. The mean size of the PFCs was 11.3 ± 3.3 cm. Fluoroscopy was used in seven cases (33%) and was associated with a longer procedure time compared to non-fluoroscopy (43.1 ± 10.4 vs 33.3 ± 10.5 min, P = 0.025). This association was independent of the size, location, or type of PFCs. Fluoroscopy had no effect on the technical success rates. In fluoroless procedures, the clinical resolution was 91% as compared to 71% in fluoroscopy procedures (P = 0.52) and the radiologic resolution was 57% as compared to 71% in fluoroscopy procedures (P = 0. 65). Three cases of stent migration/displacement occurred in the fluoroless procedures. CONCLUSIONS: ELAMS may avoid the need for fluoroscopy during cystogastrostomy. Procedures without fluoroscopy were significantly shorter and fluoroscopy use had no impact on the technical or clinical success rates.
BACKGROUND: Fluoroscopy is often used during the endoscopic drainage of pancreatic-fluid collections (PFCs). An electrocautery-enhanced coaxial lumen-apposing, self-expanding metal stent (ELAMS) facilitates a single-step procedure and may avoid the need for fluoroscopy. This study compares the treatment outcomes using ELAMS with and without fluoroscopy. METHODS: Patients with PFCs who had cystogastrostomy from January 2014 to February 2017 were enrolled. Two groups were studied based on fluoroscopy use. Technical success was defined as uneventful insertion of ELAMS at time of procedure. Clinical success was defined as (i) clinical resolution of symptoms after the procedure and (ii) >75% reduction in cyst size on computed tomography 8 weeks after stent placement. Adverse events including bleeding, stent migration, and infection were recorded. RESULTS: A total of 21 patients (13 males) had PFCs drainage with ELAMS in the study period. The mean age was 51.6 ± 14.2 years. Thirteen patients had walled-off necrosis while eight had a pancreatic pseudocyst. The mean size of the PFCs was 11.3 ± 3.3 cm. Fluoroscopy was used in seven cases (33%) and was associated with a longer procedure time compared to non-fluoroscopy (43.1 ± 10.4 vs 33.3 ± 10.5 min, P = 0.025). This association was independent of the size, location, or type of PFCs. Fluoroscopy had no effect on the technical success rates. In fluoroless procedures, the clinical resolution was 91% as compared to 71% in fluoroscopy procedures (P = 0.52) and the radiologic resolution was 57% as compared to 71% in fluoroscopy procedures (P = 0. 65). Three cases of stent migration/displacement occurred in the fluoroless procedures. CONCLUSIONS: ELAMS may avoid the need for fluoroscopy during cystogastrostomy. Procedures without fluoroscopy were significantly shorter and fluoroscopy use had no impact on the technical or clinical success rates.
Authors: Raj J Shah; Janak N Shah; Irving Waxman; Thomas E Kowalski; Andres Sanchez-Yague; Jose Nieto; Brian C Brauer; Monica Gaidhane; Michel Kahaleh Journal: Clin Gastroenterol Hepatol Date: 2014-10-05 Impact factor: 11.382
Authors: Emanuele Rinninella; Rastislav Kunda; Markus Dollhopf; Andres Sanchez-Yague; Uwe Will; Ilaria Tarantino; Joan Gornals Soler; Sebastian Ullrich; Alexander Meining; Josè Miguel Esteban; Thomas Enz; Geoffroy Vanbiervliet; Frank Vleggaar; Fabia Attili; Alberto Larghi Journal: Gastrointest Endosc Date: 2015-05-23 Impact factor: 9.427
Authors: Peter A Banks; Thomas L Bollen; Christos Dervenis; Hein G Gooszen; Colin D Johnson; Michael G Sarr; Gregory G Tsiotos; Santhi Swaroop Vege Journal: Gut Date: 2012-10-25 Impact factor: 23.059
Authors: Ali Aghdassi; Julia Mayerle; Matthias Kraft; Andreas W Sielenkämper; Claus-Dieter Heidecke; Markus M Lerch Journal: Pancreas Date: 2008-03 Impact factor: 3.327